Exploring Molecular Targeted Therapy for Hepatoceccular Carcinoma: Focus on Aurora Kinases

by Zhong-Zhe Lin, 林宗哲
Published 2010

Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status.

by Hsi-Chieh Chen, Elise Chia-Hui Tan, Chih-Hsien Liao, Zhong-Zhe Lin, Ming-Chin Yang
Published 2019-01-01

Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases

by Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, Po-Chin Liang, Ann-Lii Cheng, Zhong-Zhe Lin
Published 2013-01-01

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma

by Bang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, Chih-Hung Hsu, Ann-Lii Cheng, Chiun Hsu, Po-Chin Liang, Tiffany Ting-Fang Shih
Published 2021-07-01

<i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

by Yu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, Yao-Ming Wu, Chiun Hsu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng, Zhong-Zhe Lin
Published 2021-07-01

The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.

by Yun Chiang, James Chih-Hsin Yang, Feng-Ming Hsu, Yu-Hsuan Chen, Jin-Yuan Shih, Zhong-Zhe Lin, Keng-Hsueh Lan, Ann-Lii Cheng, Sung-Hsin Kuo
Published 2015-01-01

Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size.

by Zhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, Yu-Yun Shao, Yi-Chun Yeh, Raymond Nien-Chen Kuo, Chih-Hung Hsu, James Chih-Hsin Yang, Ann-Lii Cheng, Mei-Shu Lai
Published 2013-01-01

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer

by Wen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, Jin-Yuan Shih, Chong-Jen Yu, Zhong-Zhe Lin, Szu-Huai Lu, James Chih-Hsin Yang, Ann-Lii Cheng, Sung-Hsin Kuo
Published 2020-05-01

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song, Tawesak Tanwandee
Published 2019-12-01